Related references
Note: Only part of the references are listed.Alcohol consumption and risk for Parkinson's disease: a systematic review and meta-analysis
Felix Javier Jimenez-Jimenez et al.
JOURNAL OF NEUROLOGY (2019)
Brain cholesterol metabolism and Parkinson's disease
Xuemei Huang et al.
MOVEMENT DISORDERS (2019)
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2019)
Low Vitamin B12 and Parkinson Disease: Potential Link to Reduced Cholinergic Transmission and Severity of Disease
Stuart J. McCarter et al.
MAYO CLINIC PROCEEDINGS (2019)
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
Maria Maraki et al.
MOVEMENT DISORDERS (2019)
Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism
Guang Lin et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Francesca Garretti et al.
FRONTIERS IN IMMUNOLOGY (2019)
Projection of the Prevalence of Parkinson's Disease in the Coming Decades: Revisited
Alexander Rossi et al.
MOVEMENT DISORDERS (2018)
Functional morphology of the blood-brain barrier in health and disease
Stefan Liebner et al.
ACTA NEUROPATHOLOGICA (2018)
Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2018)
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations
David Arkadir et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Cardiac abnormalities in Parkinson's disease and Parkinsonism
Fulvio A. Scorza et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang et al.
MOVEMENT DISORDERS (2018)
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease
Seung Pil Yun et al.
NATURE MEDICINE (2018)
Association between diabetes and subsequent Parkinson disease A record-linkage cohort study
Eduardo De Pablo-Fernandez et al.
NEUROLOGY (2018)
A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients
Hong Jin et al.
NEUROSCIENCE LETTERS (2018)
RAGE and its emerging role in the pathogenesis of Parkinson's disease
Xiuli Jiang et al.
NEUROSCIENCE LETTERS (2018)
Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson's disease
Joanna Motyl et al.
PHARMACOLOGICAL REPORTS (2018)
Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease
Raymond S. Schwartz et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis
Xi-Chen Zhu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review
Steven G. Chrysant et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2018)
Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis
Katsiaryna Bykov et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation
Lawrence Anchah et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds
Natalia Mast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model
Caroline Cristiano Real et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2017)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda et al.
LANCET (2017)
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015
Marissa B. Reitsma et al.
LANCET (2017)
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Yu-Wan Yang et al.
MEDICINE (2017)
Statins May Facilitate Parkinson's Disease: Insight Gained From a Large, National Claims Database
Guodong Liu et al.
MOVEMENT DISORDERS (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Long-term effects of exercise and physical therapy in people with Parkinson disease
Margaret K. Mak et al.
NATURE REVIEWS NEUROLOGY (2017)
SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease
Cheng-yuan Mao et al.
PARKINSONISM & RELATED DISORDERS (2017)
Occupational and recreational physical activity and Parkinson's disease in Denmark
I-Fan Shih et al.
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH (2017)
Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease
Kelvin K. W. Cheng et al.
SCOTTISH MEDICAL JOURNAL (2017)
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
Robin Poole et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress
Camille B. Carroll et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
Robin Poole et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk
Lijun Zhang et al.
FRONTIERS IN NEUROLOGY (2017)
Integrated molecular landscape of Parkinson's disease
C. J. H. M. Klemann et al.
NPJ PARKINSONS DISEASE (2017)
Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial ( Prevencion con Dieta Mediterranea)
Dong D. Wang et al.
CIRCULATION (2017)
Systematic Genetic Analysis of the SMPD1 Gene in Chinese Patients with Parkinson's Disease
Sheng Deng et al.
MOLECULAR NEUROBIOLOGY (2016)
24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
Min-Yu Sun et al.
NEUROSCIENTIST (2016)
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
Diane M. A. Swallow et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia
Yi Xing et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E
Weiyan Lai et al.
KIDNEY INTERNATIONAL (2016)
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets
Alberto J. Espay et al.
LANCET NEUROLOGY (2016)
Effect of glycation inhibitors on aging and age-related diseases
Izabela Sadowska-Bartosz et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2016)
Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies
Xuejing Yue et al.
MEDICINE (2016)
Regulation of sphingomyelin metabolism
Kamil Bienias et al.
PHARMACOLOGICAL REPORTS (2016)
Prevalence and prevention of cardiovascular disease and diabetes mellitus
Pitchai Balakumar et al.
PHARMACOLOGICAL RESEARCH (2016)
C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway
Yong-Ke You et al.
SCIENTIFIC REPORTS (2016)
Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
Bram. P. Prins et al.
PLOS MEDICINE (2016)
Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease
Nicholas W. Sterling et al.
AGING AND DISEASE (2016)
Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score-matched, longitudinal follow-up study
Huey-Wen Liang et al.
AMERICAN HEART JOURNAL (2015)
Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
Jonathan Y. Xia et al.
CELL METABOLISM (2015)
Exercise and the Cardiovascular System Clinical Science and Cardiovascular Outcomes
Carl J. Lavie et al.
CIRCULATION RESEARCH (2015)
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. (vol 14, pg 795, 2015)
Chadwick W. Christine
LANCET NEUROLOGY (2015)
Plasma Fasting Cholesterol Profiles and Age at Onset in Parkinson's Disease
Philipp Mahlknecht et al.
MOVEMENT DISORDERS (2015)
Statins, Plasma Cholesterol, and Risk of Parkinson's Disease: A Prospective Study
Xuemei Huang et al.
MOVEMENT DISORDERS (2015)
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis
Luiza A. Rabelo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
SMPD1 mutations and Parkinson disease Response
E. Dagan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease
Katri Saaksjarvi et al.
PARKINSONISM & RELATED DISORDERS (2015)
The emerging role of SMPDI mutations in Parkinson's disease: Implications for future studies
Ziv Gan-Or et al.
PARKINSONISM & RELATED DISORDERS (2015)
Cardiovascular risk factors and the risk of Parkinson's disease
M. Vikdahl et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2015)
Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies
Yun-Liang Wang et al.
PLOS ONE (2015)
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni et al.
LANCET NEUROLOGY (2015)
At the Heart of Brain Disorders - Preventing Cognitive Decline and Dementia
Augusto Vicario et al.
EUROPEAN CARDIOLOGY REVIEW (2015)
Long-Term Coffee Consumption and Risk of Cardiovascular Disease A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies
Ming Ding et al.
CIRCULATION (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
Sarah K. Abbott et al.
MOVEMENT DISORDERS (2014)
System-based approaches to decode the molecular links in Parkinson's disease and diabetes
Jose A. Santiago et al.
NEUROBIOLOGY OF DISEASE (2014)
APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease
Neeraj Kumar Singh et al.
NEUROLOGICAL SCIENCES (2014)
Parkinson disease and smoking revisited Ease of quitting is an early sign of the disease
Beate Ritz et al.
NEUROLOGY (2014)
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lin Lu et al.
PLOS ONE (2014)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Holding on to statins in Parkinson disease
Eng-King Tan et al.
NEUROLOGY (2013)
Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
Ingemar Bjorkhem et al.
NEUROSCIENCE LETTERS (2013)
Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study
G. O. Skeie et al.
PARKINSONISM & RELATED DISORDERS (2013)
Alcohol Consumption, Types of Alcohol, and Parkinson's Disease
Rui Liu et al.
PLOS ONE (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
Shared dysregulated pathways lead to Parkinson's disease and diabetes
Jose A. Santiago et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease
Gulnur Andican et al.
ACTA NEUROLOGICA BELGICA (2012)
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Rui Liu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
A Ceramide-Centric View of Insulin Resistance
Jose A. Chavez et al.
CELL METABOLISM (2012)
Risk of Parkinson Disease Onset in Patients With Diabetes A 9-year population-based cohort study with age and sex stratifications
Yu Sun et al.
DIABETES CARE (2012)
The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain
D. Domenger et al.
EXPERIMENTAL NEUROLOGY (2012)
Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Anna-Maija Tolppanen et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Metabolic markers or conditions preceding Parkinson's disease: A case-control study
Rodolfo Savica et al.
MOVEMENT DISORDERS (2012)
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women
Natalia Palacios et al.
MOVEMENT DISORDERS (2012)
The association between Mediterranean diet adherence and Parkinson's disease
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2012)
A large study reveals no association between APOE and Parkinson's disease
Monica Federoff et al.
NEUROBIOLOGY OF DISEASE (2012)
Cholesterol: Its Regulation and Role in Central Nervous System Disorders
Matthias Orth et al.
CHOLESTEROL (2012)
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis
Micha M. M. Wilhelmus et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Use of Genotype Frequencies in Medicated Groups to Investigate Prescribing Practice: APOE and Statins as a Proof of Principle
Neil M. Davies et al.
CLINICAL CHEMISTRY (2011)
Diabetes and Risk of Parkinson's Disease A systematic review and meta-analysis
Emanuele Cereda et al.
DIABETES CARE (2011)
Diabetes and the Risk of Developing Parkinson's Disease in Denmark
Eva Schernhammer et al.
DIABETES CARE (2011)
Diabetes and Risk of Parkinson's Disease
Qun Xu et al.
DIABETES CARE (2011)
Association of Blood Pressure and Hypertension With the Risk of Parkinson Disease The National FINRISK Study
Chengxuan Qiu et al.
HYPERTENSION (2011)
Obesity, Diabetes, and Risk of Parkinson's Disease
Natalia Palacios et al.
MOVEMENT DISORDERS (2011)
Prospects of Statins in Parkinson Disease
Avik Roy et al.
NEUROSCIENTIST (2011)
An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease
Jianjun Gao et al.
PLOS ONE (2011)
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
Xuemei Huang et al.
PLOS ONE (2011)
Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
Yoshihiro Miyake et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Physical activities and future risk of Parkinson disease
Q. Xu et al.
NEUROLOGY (2010)
Smoking duration, intensity, and risk of Parkinson disease
H. Chen et al.
NEUROLOGY (2010)
Risk of stroke in patients with idiopathic Parkinson disease
Claudia Becker et al.
PARKINSONISM & RELATED DISORDERS (2010)
The cause of death in idiopathic Parkinson's disease
Susan Pennington et al.
PARKINSONISM & RELATED DISORDERS (2010)
Smoking and Parkinson's Disease: Using Parental Smoking as a Proxy to Explore Causality
Eilis J. O'Reilly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Different Patterns of Oxidized Lipid Products in Plasma and Urine of Dengue Fever, Stroke, and Parkinson's Disease Patients: Cautions in the Use of Biomarkers of Oxidative Stress
Chung-Yung J. Lee et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
Sehee Kim et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's Disease
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY (2009)
Diabetes preceding Parkinson's disease onset. A case-control study
Marco D'Amelio et al.
PARKINSONISM & RELATED DISORDERS (2009)
Diabetes in patients with idiopathic Parkinson's Disease
Claudia Becker et al.
DIABETES CARE (2008)
Soy protein intake, carchorenal indices, and C-reactive protein in type 2 diabetes with nephropathy - A longitudinal randomized clinical trial
Leila Azadbakht et al.
DIABETES CARE (2008)
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver et al.
DIABETES CARE (2008)
Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study
J. Hippisley-Cox et al.
HEART (2008)
Glucagon-like peptide I receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
Alexander Harkavyi et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
Xuemei Huang et al.
MOVEMENT DISORDERS (2008)
Recreational physical activity and risk of Parkinson's disease
Evan L. Thacker et al.
MOVEMENT DISORDERS (2008)
Use of antihypertensives and the risk of Parkinson disease
Claudia Becker et al.
NEUROLOGY (2008)
Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation
Tiina Kotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Kelly Claire Simon et al.
NEUROLOGY (2007)
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson Disease
Lonneke M. L. de Lau et al.
MOVEMENT DISORDERS (2007)
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease
Xuemei Huang et al.
MOVEMENT DISORDERS (2007)
Crossing the barrier:: oxysterols as cholesterol transporters and metabolic modulators in the brain
I. Bjorkhem
JOURNAL OF INTERNAL MEDICINE (2006)
Serum cholesterol levels and the risk of Parkinson's disease
Lonneke M. L. de lau et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Lipid dynamics in neurons
J. E. Vance et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Reduced risk factors for vascular disorders in Parkinson disease patients - A case-control study
G Scigliano et al.
STROKE (2006)
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
TJ Kotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk
KM Powers et al.
PARKINSONISM & RELATED DISORDERS (2006)
Physical activity and the risk of Parkinson disease
H Chen et al.
NEUROLOGY (2005)
Risk and protective factors for Parkinson's disease: A study in Swedish twins
K Wirdefeldt et al.
ANNALS OF NEUROLOGY (2005)
Obesity and the risk of Parkinson's disease
HL Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease
XM Huang et al.
NEUROLOGY (2004)
Brain cholesterol:: Long secret life behind a barrier
I Björkhem et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Survival time, mortality, and cause of death in elderly patients with Parkinson's disease:: A 9-year follow-up
PA Fall et al.
MOVEMENT DISORDERS (2003)
Weight loss in Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
CNS synaptogenesis promoted by glia-derived cholesterol
DH Mauch et al.
SCIENCE (2001)
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
A Ascherio et al.
ANNALS OF NEUROLOGY (2001)
Risk factors for Parkinson's disease: The Leisure World cohort study
A Paganini-Hill
NEUROEPIDEMIOLOGY (2001)
Causes of death in a community-based study of Parkinson's disease
MK Beyer et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Share Paper
